Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
731.35
Change Change %
-31.35 -4.11%

Updated:24 Sep, 2018, 15:59 PM IST

BSE
730.45
Change Change %
-31.20 -4.10%

Updated:24 Sep, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
IDFC
N/A
22-07-2016 Buy 790.00 976.00
N/A
Closed Long (1Y)
22-07-2017

IDFC initiates Aurobindo Pharma with outperform

Aurobindo is now comparable with large-cap peers. Company has superior execution track record in the recent past. Aurobindo's valuation is at 25-30 per cent discount to large-cap peers. The company will give sustained delivery momentum. Large M&A transaction is a key risk to our re-rating thesis.

Top